Metabolic / Weight Management

Tirzepatide

A dual GLP-1/GIP receptor agonist at the forefront of metabolic research.

Evidence: 24 articles
Goals: 1

Mechanism of Action

Compound targeting metabolic efficiency and cellular energy production.

Evidence Level

Preclinical Model

24 studies published

Pharmacology

ARIA · Sign in to chat